Access & Product Management

Ensuring access


"We are not just focusing on developing drugs…. The issue of access is also very important…, ensuring that people who need these drugs will have access to them."

Dr Awa Marie Coll-Seck,
Minister of Health in Senegal
Former Executive Director, RBM Partnership

MMV's Access & Product Management Advisory Committee (APMAC) provides expert advice to MMV on how to ensure timely and effective delivery of new antimalarials in endemic countries.

Interactive Map

This map provides a global view of our Access & Product Management projects.

Global Malaria Mapper

This new map tool allows users to create maps using World Malaria Report data

Latest Access publication

Produced by the WHO Global Malaria Programme - Seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in children: A field guide

Access team

The Access team works closely with Ministries of Health, pharmaceutical partners, international agencies, and the global health community to lay the ground for access to the products in MMV's portfolio.

Contact us

Supporting introduction

MMV seeks to minimize the time-to-market for the responsible introduction and acceptance of important new therapies in malaria endemic countries.

Enhancing reach

MMV supports expanded access to quality malaria treatments in endemic countries, primarily by working with partners on improving public & private sector delivery in malaria endemic countries.

Informing R&D

MMV monitors the experience of patients and providers with launched medicines to help inform the R&D process, thus ensuring future products will better address unmet patient needs.

Gathering Market Intelligence

MMV endeavors to ensure timely availability of key market data to inform product development, launch and scale-up.